CSIMarket Company Name, Ticker, Industry, else..
 
Vaso Corporation  (VASO)
Other Ticker:  
 
 
Price: $0.2320 $-0.01 -2.929%
Day's High: $0.2395 Week Perf: -14.07 %
Day's Low: $ 0.23 30 Day Perf: -18.17 %
Volume (M): 32 52 Wk High: $ 0.29
Volume (M$): $ 7 52 Wk Avg: $0.15
Open: $0.23 52 Wk Low: $0.06



 Market Capitalization (Millions $) 40
 Shares Outstanding (Millions) 174
 Employees -
 Revenues (TTM) (Millions $) 81
 Net Income (TTM) (Millions $) 1
 Cash Flow (TTM) (Millions $) 7
 Capital Exp. (TTM) (Millions $) 0

Vaso Corporation


   Company Address: 137 Commercial St. Plainview 11803 NY
   Company Phone Number: 997-4600   Stock Exchange / Ticker: VASO
   VASO is expected to report next financial results on March 30, 2023.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Guess Inc

Very apparent Contraction in Sales at GES in the most recent fiscal period

GES reported earnings per share gain of 34.32 % to $1.40 on fading Sales of -9.735 % to $722.07 millions in the most recent fiscal period, year on year.

Security Federal Corporation

Strong Eps Underlines Double Digits Sales advance at in the fiscal period closing December 31 2022

Considering the Dec 31 2022 report bottom-line jumped by 62.16 % to $1.01 per share, followed by Sales increase of 14.164 % to $13.11 millions, compared with the prior year period.

Aptose Biosciences Inc

Aptose Biosciences Inc added some positive scenario for the shareholders, presenting a significant improvement in fiscal interval ending December 31 2022 with operating deficit of $-10.403 millions

Trailing the bellwethers in the Biotechnology & Pharmaceuticals sector, some overlooked corporations are publishing the numbers. APTO said it has clinched operating deficit of $-10.403 millions, for the fourth quarter of 2022.

Meta Materials Inc

Evanescence of Losses at MMAT amid the financial period ending December 31 2022

For the financial period ending December 31 2022 company decreased a loss per share of $-0.03 per share compare to $-0.22 a year prior and EPS improved from $-0.07 per share from the previous financial reporting period.

Sales faded by -49.855 % to $1.45 millions from $2.88 millions in the corresponding financial reporting period a year prior and sequentially Sales Tumbled by -41.135 % from $2.46 millions.

Aslan Pharmaceuticals Limited

The company released operating loss of $-47.882487 millions, in the most recent fiscal period

As the October to December 31 2022 reporting season goes on, many businesses have announced the respective numbers. In the thick of it, are many constituents of the Biotechnology & Pharmaceuticals sector. As well as, now, ASLN issued operating loss of $-47.882487 millions, for the most recent fiscal period.






 

Vaso's Segments
 
 
• View Complete Report


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

 Stocks


Event Calendar

DDL's Profile

Stock Price

DDL's Financials

Business Description

Fundamentals

Charts & Quotes

DDL's News

Suppliers

DDL's Competitors

Customers & Markets

Economic Indicators

DDL's Growth

Company Segments

 Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness
Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

 Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

 News


At a Glance

Stocks

Economy

Industries

Other
Help


Sitemap

Advertise

About us

 Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071